EDRS: Ecstasy and related Drugs Reporting System

The EDRS provides nationally comparable data from each Australian jurisdiction in relation to patterns of ecstasy and related drug use, associated harms, and provides evidence for better informing future policy, program and research initiatives.




CLICK HERE to download results.


Some recent findings of EDRS data that allow identification of emerging trends in the ecstasy and related drug market and which can be a basis for further research are listed below:

2010 & 2011: An increase in the use of emerging psychoactive substances such as Mephedrone and DMT was reported which may have also been influenced by the continued lack of availability of ecstasy in Victoria.

2009: An apparent reduction in the availability of ecstasy in Victoria may have influenced an increase in the use of other drugs such benzodiazepines (e.g. Valium, Xanax), LSD, Amyl Nitrite and “designer (hallucinogenic) drugs”.

2008: Detection of the emerging use of Khat (Catha edulis) among Victorian participants.


The national EDRS is coordinated by the National Drug and Alcohol Research Centre (NDARC) at the University of New South Wales (UNSW) in Sydney.


The Australian Government Department of Health and Ageing (AGDHA)

Contact Details

For any general enquiries relating to this project, please contact:

Professor Paul Dietze

Program Director, Behaviours and Health Risks